新华医疗: 新华医疗关于控股股东取得增持股份专项贷款承诺函的公告

Group 1 - The core point of the announcement is that the controlling shareholder, Shandong Yiyang Health Industry Development Group Co., Ltd., plans to increase its stake in Xinhua Medical through a loan commitment from Industrial and Commercial Bank of China, Shandong Branch, amounting to no more than RMB 180 million [1][2] - The increase plan is based on the confidence in Xinhua Medical's future stable development and long-term investment value, with a planned investment amount between RMB 100 million and RMB 200 million within 12 months starting from May 27, 2025 [1] - The loan commitment from the bank is specifically for the purpose of supporting the increase in A-share stock, with a loan term not exceeding 3 years [2]